×
In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes.
Ai Ng SY., Zhu D., Herrington WG.
DOI
10.7326/ACPJ202002180-018
Type
Journal article
Journal
Ann Intern Med
Publication Date
18/02/2020
Volume
172